Complex Generic Formulations: Why Proving Bioequivalence Is So Hard
Complex generic formulations face unique challenges in proving bioequivalence due to their delivery mechanisms, manufacturing complexity, and lack of standardized testing methods - making them harder to approve than simple generics.
- 0